IM8
A health drink startup associated with David Beckham develops wellness beverages and secured $1 billion from General Catalyst’s CVF fund.
Overview
IM8 is a health drink startup linked to David Beckham, focused on consumer wellness beverages. The available funding context identifies the company as building health drinks rather than AI software, infrastructure, or clinical healthcare technology. The company’s profile is defined by its celebrity association and unusually large financing: a $1 billion undisclosed round from General Catalyst’s CVF fund in July 2026. The scale of the investment suggests a significant push into the consumer health and wellness market.
Funding History
David Beckham’s health drink startup IM8 takes $1B from General Catalyst’s unusual CVF fund
Frequently Asked Questions
- How much funding does AI Funding track for IM8?
- AI Funding tracks $1.0B for IM8 across 1 funding round in this database.
- Who are IM8's investors?
- IM8's investors include General Catalyst.
- What does IM8 do?
- IM8 is a health drink startup linked to David Beckham, focused on consumer wellness beverages. The available funding context identifies the company as building health drinks rather than AI software, infrastructure, or clinical healthcare technology. The company’s profile is defined by its celebrity association and unusually large financing: a $1 billion undisclosed round from General Catalyst’s CVF fund in July 2026. The scale of the investment suggests a significant push into the consumer health and wellness market.
- Where is IM8 headquartered?
- IM8 is headquartered in San Francisco, CA.
Investors
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.